= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Improved Process For Preparation Of Betrixaban Maleate 参考文献:India]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Unit Dose Formulations And Methods Of Treating Thrombosis With An Oral Factor Xa Inhibitor,And In Vitro Assay For Antithrombotic Activity Prediction 参考文献:World Intellectual Property Organization]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Methods For Preparing Pharmaceutical Salts Of A Factor Xa Inhibitor 参考文献:World Intellectual Property Organization]
9005-53-2 = 110-16-7 + 110-17-8 + 141-82-2 + 6915-15-7 + 87-69-4 + 110-15-6 + 144-62-7 反应条件:1.1R:H2So4,R:H2O2 标题:Electrochemical Conversion Of Lignin To Short-Chain Carboxylic Acids 作者:By Sun,Shirong Et Al 参考文献:Green Chemistry 日期:2023 卷标:25(8) 页码:3127-3136]
9004-34-6 = 110-16-7 + 110-17-8 + 141-82-2 + 79-14-1 + 110-15-6 + 144-62-7 反应条件:1.1R:R:O2,S:H2O,175°C,30 Bar 标题:Lignin Alkaline Oxidation Using Reversibly-Soluble Bases 作者:By Kruger,Jacob S. Et Al 参考文献:Green Chemistry 日期:2022 卷标:24(22) 页码:8733-8741]
= 110-16-7 + 65-85-0 + 100-52-7 + 144-62-7 反应条件:1.1R:O2,C:Mn,C:Al2O3,C:Ag 标题:Probing The Effects Of Plasma-Induced Surface Species In Ring-Opening Process Of Toluene Decomposition Via Plasma-Excited Tpd And In Situ Drifts 作者:By Sun,Yuhai Et Al 参考文献:Journal Of Cleaner Production 日期:2022 卷标:371 页码:133332]
= 110-16-7 + 97529-85-6 + 26447-28-9 反应条件:1.1 Reagents: Perchloric Acid Catalysts: Palladium 标题:Insight Into The Oxidation Mechanism Of Furanic Compounds On Pt(111) 作者:Mark,Lesli O.; Agrawal,Naveen; Roman,Alex M.; Holewinski,Adam; Janik,Michael J.; Et Al 参考文献:Acs Catalysis 日期:2019 卷标:9(12) 页码:11360-11370]
88150-42-9 + 110-16-7 = 110-16-7 + 88150-42-9 反应条件:1.1 Solvents: Ethyl Acetate; 3 H,Rt 标题:Synthesis Of Amlodipine Maleate 作者:Xu,Feng; Et Al 参考文献:Anhui Huagong 日期:2013 卷标:39(3) 页码:23-24]
330942-05-7 + 110-16-7 = 110-16-7 + 330942-05-7 反应条件:1.1 Solvents: Acetone; 30 Min,55 - 60 °C 标题:Process For Preparing Amorphous Form Of Betrixaban Maleate Containing Solvent And Antisolvent 参考文献:India]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Process For The Preparation Of N-(5-Chloropyridin-2-Yl)-2[4-(N,N-Dimethylcarbamimidoyl)-Benzoylamino]-5-Methoxybenzamide And Its Pharmaceutically Acceptable Salts 参考文献:India]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:A Process For Preparation Of Betrixaban Hydrochloride And Betrixaban Maleate Salt 参考文献:India]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Methods Of Synthesizing Pharmaceutical Salts Of A Factor Xa Inhibitor 参考文献:United States]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Crystalline Forms Of A Factor Xa Inhibitor 参考文献:World Intellectual Property Organization]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Process For Preparation Of Betrixaban And Maleate Salt As Factor Xa Inhibitors 参考文献:World Intellectual Property Organization]
= 110-16-7 + 330942-05-7 [标题:Reaction Conditions 标题:Pharmaceutical Salt And Polymorph Of Factor Xa Inhibitor 参考文献:World Intellectual Property Organization]
90445-12-8 = 110-16-7 + 88150-42-9 反应条件:1.1 Reagents: Triethylamine,Hydroxyamine Hydrochloride Solvents: Isopropanol,Water; 5 H,Reflux2.1 Solvents: Ethyl Acetate; 3 H,Rt 标题:Synthesis Of Amlodipine Maleate 作者:Xu,Feng; Et Al 参考文献:Anhui Huagong 日期:2013 卷标:39(3) 页码:23-24]
专利号:US-2024208900-A1 优先权日:2021-04-16 标题 :Synthesis of dimethyl-c17-32-alkyl sulfonium salts 发明人:STROOT JOERG; ZHERSH SERHII; RIPENKO VASYL 权利人:HELM AG 摘要:The invention relates to a process for the preparation of a dimethyl-C 17-32 -alkyl sulfonium salt, preferably a dimethyl-C 17-32 -alkyl sulfonium halide, more preferably a dimethyl-C 17-32 -alkyl sulfonium chloride, still more preferably dimethyl octadecyl sulfonium chloride, the process comprising the steps of: providing a mixture of a C 17-32 -alkyl halide and dimethyl sulfide; and reacting the C 17-32 -alkyl halide with the dimethyl sulfide.
专利号:US-5124460-A 优先权日:1991-05-06 标 题 :Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes 发明人:HUMPHREY GUY R 权利人:MERCK SHARP & DOHME 摘要:A process for preparing a substantially pure enantiomer of a compound formula (I) ##STR1## wherein X is O or S; and n R 2 represents hydrogen, --CF 3 , --OR 7 , --SR 7 , --NR 7 R 8 , --CN, --COOR 7 , --CONR 7 R 8 , or a saturated or unsaturated, substituted or unsubstituted hydrocarbon group, wherein R 7 and R 8 are independently selected from hydrogen and C 1-2 alkyl provided that --NR 7 R 8 is other than NH 2 ; n which process comprises cyclization of a compound of formula (10) or salt thereof: ##STR2## wherein X and R 2 are as defined in formula (I); and R 4 is a labile leaving group and optionally epimerizing the endo-diastereomer so prepared to produce the corresponding exo-diastereomer.
专利号:WO-2009140467-A1 优先权日:2008-05-15 标 题:Oxobenzindolizinoquinolines and uses thereof 发明人:CUSHMAN MARK S; CINELLI MARIS A; MORRELL ANDREW E; POMMIER YVES G 权利人:PURDUE RESEARCH FOUNDATION; CUSHMAN MARK S; US GOV HEALTH & HUMAN SERV; CINELLI MARIS A; MORRELL ANDREW E; POMMIER YVES G 摘要:The synthesis of aromathecins, substituted 12 H -5,l la-diazadibenzo[ b,h ]fluoren- 11 -ones is described. Use of these cytotoxic compounds and pharmaceutical compositions containing them for the treatment of cancer is described. Two novel processes for the synthesis of this system and a series of 14-substituted aromathecins as novel cytotoxic, topoisomerase I poisons are described.
专利号:US-11406709-B2 优先权日:2014-09-15 标 题 :Therapeutic and research application of PDCL3 发明人:RAHIMI NADER 权利人:UNIV BOSTON 摘要:Described herein are novel compositions comprising, for example, PDCL3 polypeptides having VEGFR-2 inhibitory activity, inhibitory PDCL3 antibodies and PDCL3-binding fragments thereof, or PDCL3 inhibitory nucleic acid molecules, and methods of their use in anti-angiogenesis and anti-tumor proliferation and invasiveness therapies, such as the treatment of cancer, as well as the treatment of those vascular diseases where pathological angiogenesis plays a role, such as in carotid artery disease, macular degeneration, and plaque neovascularization. Also described herein are novel compositions comprising engineered PDCL3 polypeptides having enhanced chaperone activity, recombinant cells comprising such engineered PDCL3 polypeptides having enhanced chaperone activity, and methods thereof for therapeutic protein production and in vitro protein synthesis.
专利号:CN-117242054-A 优先权日:2021-04-16 标 题 :Synthesis of dimethyl-C17-32 alkyl sulfonium salt
专利号:WO-2022218721-A1 优先权日:2021-04-16 标题:Synthesis of dimethyl-c17-32-alkyl sulfonium salts
[参考文献]: Fonda Ml, Et Al. Glutamate Decarboxylase. Substrate Specificity And Inhibition By Carboxylic Acids. Biochemistry. 1972 Mar 28;11(7):1304-9. [参考文献]: Paudyal R, Et Al. A Novel Approach In Acidic Disinfection Through Inhibition Of Acid Resistance Mechanisms; Maleic Acid-Mediated Inhibition Of Glutamate Decarboxylase Activity Enhances Acid Sensitivity Of Listeria Monocytogenes. Food Microbiol. 2018 Feb;69:96-104. [参考文献]: Atsushi Kambayashi, Et Al. Predicting The Oral Pharmacokinetic Profiles Of Multiple-Unit (Pellet) Dosage Forms Using A Modeling And Simulation Approach Coupled With Biorelevant Dissolution Testing: Case Example Diclofenac Sodium. Eur J Pharm Biopharm. 2014 Jul;87(2):236-43. [参考文献]: F Guneral, Et Al. Age-Related Reference Values For Urinary Organic Acids In A Healthy Turkish Pediatric Population. Clin Chem. 1994 Jun;40(6):862-6. [参考文献]: Marlena K Sheridan, Et Al. Exogenous Acetaldehyde As A Tool For Modulating Wine Color And Astringency During Fermentation. Food Chem. 2015 Jun 15:177:17-22.
合成参考文献
参考文献:10.1097/01.ijg.0000212210.33265.24 摘要:Liu Y, Yanai R, Lu Y, Hirano S, Sagara T, Nishida T. Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. J Glaucoma. 2006 Jun;15(3):255–9. doi: 10.1097/01.ijg.0000212210.33265.24. 参考文献:10.1016/s0161-6420(92)31847-0 摘要:Herreras JM, Pastor JC, Calonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992 Jul;99(7):1082–8. doi: 10.1016/s0161-6420(92)31847-0. 参考文献:10.1094/mpmi-19-0998 摘要:Barsch A, Tellström V, Patschkowski T, Küster H, Niehaus K. Metabolite profiles of nodulated alfalfa plants indicate that distinct stages of nodule organogenesis are accompanied by global physiological adaptations. Mol Plant Microbe Interact. 2006 Sep;19(9):998–1013. doi: 10.1094/mpmi-19-0998.